Navigation Links
Reportlinker Adds Anti-aging Products and Services: The Global Market Report
Date:9/3/2009

LOGIES

COSMETIC TECHNOLOGIES 179

LASER/ENERGY-BASED COSMETIC TREATMENTS 179

LED-based Laser Cosmetic Treatments to Be Commercialized for Home Use Aesthetic Procedures 179

Levulan PDT--The Next Blockbuster Technology 180

Top Cosmetic Laser Companies 180

TABLE 196 TOP COSMETIC LASER MANUFACTURERS, 2007 ($ MILLIONS) 180

TABLE 197 NEW PRODUCTS AND TECHNOLOGY 181

TABLE 197 (CONTINUED) 182

CUTTING EDGE TECHNOLOGY DEVELOPMENTS IN COSMETIC AND DISEASE TREATMENT 182

TABLE 198 COSMETIC AND DISEASE TREATMENT TECHNOLOGY DEVELOPMENTS 182

TABLE 198 (CONTINUED) 183

CUTTING EDGE DEVELOPMENTS IN DISEASE-SPECIFIC ANTI-AGING THERAPIES 183

METABOLIC 184

Correction of Enzymopathies Can Treat Many Metabolic Diseases 184

Prevention of Atherogenesis--Most Important Anti-aging Objective While Treating Metabolic Syndrome Patients 184

ALZHEIMER'S 184

DIABETES 185

Hormone Therapy Minimizes Endogenous and Exogenous Glycation and Reduces the Risk of Diabetic Complications. 185

WEIGHT LOSS 185

Herbal Extracts--Bauhinia Helps in Weight Loss 185

Lipolysis--An Alternative to Liposuction. 185

BRAIN HEALTH TECHNOLOGIES 185

Imaging Silent Disease to Reverse Aging of the Entire Brain and Body 186

Brain-Gut Health Connection Helps to Prevent and Reverse Brain Disorders 186

CAM Therapy of Training the Central Nervous System (CNS) to Feel Good 186

Replacement of Deficient Hormones Post Traumatic Brain Injury (TBI) Helps in Treatment 186

Physicians Are Conducting In-depth Review of Physiological Parameters of Brain Dysfunction Patients 186

New Pharmacological Strategies in Association with HO-1 Gene Therapy to Treat Brain Aging Situations 187

Neurohormones Affect Mind-Body Balance 187

BONE AND JOINT HEALTH 187

Human Tripeptide GHL Helps in Treating Bon
'/>"/>

SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related medicine news :

1. Reportlinker Adds Therapeutics for Memory and Cognition Disorders Report
2. Reportlinker Adds Healthcare Information Technology Report
3. Reportlinker Adds World Markets for Fermentation Ingredients Report
4. Reportlinker Adds The Market for Minimally Invasive Medical Devices Report
5. Reportlinker Adds Therapeutics and Diagnostics for Womens Disorders Report
6. Reportlinker Adds 2008/2009 Healthcare Research Review Report
7. Reportlinker Adds Botanical and Plant-Derived Drugs: Global Markets Report
8. Reportlinker Adds Pediatric Health Care Products and Services Report
9. Reportlinker Adds the Dental Market: Techniques, Equipment and Materials Report
10. Reportlinker Adds Membrane & Separation Technology News Review, 2008 Report
11. Reportlinker Adds Commercial Amino Acids Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... of hearing aids has been brought into reach for many Houstonians ... based hearing plan. , ... (PRWEB) December 16, 2009 ... for many Houstonians with the announcement by Hearing Haven, LLC of ... hearing better on the job, and want to improve communications and ...
(Date:12/16/2009)... Ltd. is proud to announce being presented with the Weatherhead 100 ... the fastest growing companies in Northeast Ohio and is a testament ... , ... (PRWEB) December 16, 2009 -- ... the Weatherhead 100 Upstart Award on December 3, 2009. The ...
(Date:12/16/2009)... development of products that help survivors of stroke and other ... publication of an interview with the inventors of their brand ... Therapy and Rehab Medicine, vol. 20, issue 20, page 26, ... ... (PRWEB) December 16, 2009 -- In the publication, ...
(Date:12/16/2009)... will continue to offer free nationwide confidential legal consultations for ... effects such as: Birth Defects, Attempted Suicide, Suicide and Addiction ... free at 1-800-856-6405 or go to the firm’s website at ... form. , ... (PRWEB) December 16, ...
(Date:12/16/2009)... carrying Dr. Shapio,s Help Hair Shake in all of the Florida Whole ... ... 2009 -- Dr. Larry Shapiro, hair transplant and hair loss ... be carrying the Help Hair Whey Protein Shake. Dr. Shapiro developed ... adjunct for weight loss programs, working out and muscle building., , , ...
Breaking Medicine News(10 mins):Health News:Monthly Subscription Hearing Aid Plan Announced for Houston 2Health News:Request A Test Receives Weatherhead 100 Upstart Award 2Health News:New Tailwind Device Improves Arm Function in Stroke Survivors with Paralysis 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free Legal Consultations For Users of Paxil 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free Legal Consultations For Users of Paxil 3Health News:Florida Whole Foods Stores to Carry Dr. Lawrence Shapiro's Help Hair Shake 2
... neurological reward responses , MONDAY, Dec. 3 (HealthDay News) ... brain activity patterns than those who,ve never had the ... at the University of Pittsburgh School of Medicine used ... women who,d recovered from anorexia -- defined as maintaining ...
... are clumps of fiber-like misfolded proteins which many ... , While effective treatment remains an elusive goal, ... chemists suggests a possible new approach. , ... students managed to capture and characterize a crucial ...
... Crawford brings more than 30 years of experience in Public Safety ... ... ESi(R), the global leader in,crisis information management technology, today announced ... Northeast.,Crawford is based in Boston, where he is responsible for ESi ...
... conference to discuss new Medicaid generic prescription drug,reimbursement rule ... use his,power to make sure the legislative fix is ... to be fully implemented in early,2008, will grossly underpay ... Brad Hall, Executive Director of the Kentucky Pharmacists ...
... 3 inVentiv Health, Inc.,(Nasdaq: VTIV ) today ... be held Tuesday, December 11th, 2007 in New York ... 9:00 a.m. as announced earlier, and,will conclude at noon, ... business overview, presentations by the,leaders of each of the ...
... ReBuilder Medical,Technologies, Inc. (Pink Sheets: RBRM), developers ... peripheral neuropathy, Molluscum,Contagiosum, and MRSA announces record profits ... ), "Corporate profits increased by 100% over ... disclosure will be released on our annual report,in ...
Other Medicine News:Health News:Brain Activity Points to Origins of Anorexia 2Health News:UIC chemists characterize Alzheimer's neurotoxin structure 2Health News:ESi Announces Strategic New Hire in Boston 2Health News:Kentucky Pharmacists Event Urging Senate Minority Leader McConnell to Fix Flawed Medicaid Drug Reimbursement Rule 2Health News:inVentiv Health Provides Updated Information on December 11th Investor Day 2Health News:inVentiv Health Provides Updated Information on December 11th Investor Day 3Health News:ReBuilder Medical Technologies, Inc. Reports Doubled Profits for October 2
(Date:12/15/2009)... Services, Inc. (NYSE: WST ) today announced ... the first-quarter 2010 cash dividend of $0.16 per share. ... to shareholders of record on January 20, 2010. ... global manufacturer of components and systems for injectable drug ... and disposable components used in syringe, IV and blood ...
(Date:12/15/2009)... Del., Dec. 15 The U.S. Food and ... (EMDAC) today voted 12 yes, 4 no, and 1 ... the observed risks to support the use of CRESTOR® ... Men greater than or equal to 50 years, ... Fasting LDL < 130 mg/dL; hsCRP greater than ...
(Date:12/15/2009)... SRI International, an independent nonprofit research and development ... 7,592,021 for a new bioadhesive drug delivery system ... human body,s mucous membranes. This needle-free option uses ... much longer release time compared to alternatives such ... an effective means to introduce drugs across the ...
Breaking Medicine Technology:Favorable Vote from FDA Advisory Committee on Benefit/Risk of CRESTOR(R) (rosuvastatin calcium) in JUPITER Study 2Favorable Vote from FDA Advisory Committee on Benefit/Risk of CRESTOR(R) (rosuvastatin calcium) in JUPITER Study 3Favorable Vote from FDA Advisory Committee on Benefit/Risk of CRESTOR(R) (rosuvastatin calcium) in JUPITER Study 4Favorable Vote from FDA Advisory Committee on Benefit/Risk of CRESTOR(R) (rosuvastatin calcium) in JUPITER Study 5SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System 2SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System 3SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System 4SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System 5Are intravenous treatments safe 3F New research raises doubts 55731 1Are intravenous treatments safe 3F New research raises doubts 55731 2Open source DNA 55727 1New developments in reproductive medicine 9741 1New developments in reproductive medicine 9741 2
... Biotechnologies,announced today the results of Phase I/II and ... sarcoma and osteosarcoma, as,presented by Dr. Sant P. ... held in London UK on November 13-15, 2008. ... period up to 9 months. Analysis of,safety and ...
... PHILADELPHIA, Nov. 20 GlaxoSmithKline (NYSE: GSK ... and Drug Administration (FDA) granted accelerated approval for ... patients with chronic immune (idiopathic) thrombocytopenic purpura (ITP) ... immunoglobulins or splenectomy. The approval is a significant ...
Other Medicine Technology:Rexin-G Controls Tumor Growth and Improves Survival in Chemotherapy-Resistant Soft Tissue Sarcoma and Osteosarcoma: Phase I/II & Confirmatory Phase II Studies 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 3FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 4FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 5FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 6FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 7FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 8
Four 62 mirrors give a 360 view of the anterior chamber angle with only a slight lens rotation. Posterior pole can be viewed through center of lens....
Two opposing 62 mirrors provide a complete view of the anterior chamber angle with only a 180 lens rotation. Methylcellulose and no methylcellulose designs available....
Lacrimal cannula blunt tip with 0.3 mm side port, straight....
McIntyre lacrimal cannula, dual 0.3 mm side ports, straight....
Medicine Products: